ROTARIX liquid susp orale tb 1.5 ml
7680601500043
CH-60150
J07BH01
08.08.
Reimbursement limitations:
0808 NEU
La prise en charge des coûts des vaccins au titre de mesure préventive dans le …
1 / 3
google
Details
- Product number
- 6015001
- CPT
- -
- Packaging group
- 1
- Unit
- Einzeldose(n)
- Composition
- Vaccinum attenuatum: rotavirus humanus (Stamm: RIX4414) min 1 Mio U., aqua q.s. ad suspensionem pro 1.5 ml.
Articles (1)
Rotarix liquid, orale Suspension
suspension
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
VACA
|
- | Substance | Wirkstoff (Principe actif) |
|
saccharum
|
1073.0 MG | Substance | HBESI |
|
dinatrii adipas
|
- | Substance | HNIDK |
|
Dulbecco's modified eagle medium
|
- | Substance | HNIDK |
|
phenylalaninum
|
15.0 UG | Substance | HBESI |
|
glucosum
|
0.01 MG | Substance | HBESI |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
32.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 59.20
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2024
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 60150
- Drug name
- Rotarix liquid, orale Suspension
- Galenic form
- SUOR
- ATC Code
- J07BH01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 14/05/2009
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ROTARIX liquid susp orale tb 1.5 ml
- Description (DE)
- ROTARIX liquid Susp oral Tb 1.5 ml
- Market launch
- 13/05/2009
- Narcotic (BTM)
- No
Application methods
ORA